- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
AI-Fueled COVID-19 Detection Algorithm Slices Report Time 30 Percent
RADLogics’ CEO Moshe Becker discusses the potential role of the chest CT AI tool and the impact it could make into the future.
A radiology workflow artificial intelligence (AI) solution from RADLogics can help providers truncate their turn-around time for COVID-19 detection cases by up to 30 percent, according to a recently released study.
According to a clinical trial conducted at the Moscow Center for Diagnostics & Telemedicine, employing this AI solution to evaluate chest CT scans can shave 7 minutes off the time needed to produce a radiology report.
The study included 128,350 chest CT scans – 36,358 of which were assessed with the RADLogics algorithm – as well as 570 radiologists from more than 130 hospitals and outpatient facilities. The results were discussed earlier this month during ECR 2021.
Diagnostic Imaging spoke with Moshe Becker, chief executive officer and co-founder of RADLogics, about what makes this algorithm unique for use during the pandemic, as well as what benefits it provides for both radiologists and patients. In addition, he pointed to how the tool can be used as more vaccines are administered and the pandemic, potentially, begins to dissipate.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
